cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.7928972
title: Republic Print Dataset

description: The republic print dataset consists of 107 ground truthed scans Using annotation software provided through the Transkribus Platform we annotated scans, concerning mostly 18th century printed documents from the National Archive of the Netherlands, with their layout consisting of baselines and regions. The resulting ground truth was used to train a machine learning model yielding very accurate results. The ground truth was made available as an open access dataset.
DOI: 10.14272/llvfbekedcmpgv-mdwzmjqesa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) ()
title: InChI=1S/C12H14N6O2/c1-8(9-2-4-10(19)5-3-9)13-16-12(20)7-6-11-14-17-18-15-11/h2-5,19H,6-7H2,1H3,(H,16,20)(H,14,15,17,18)/b13-8+

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR) 1H NMR (400 MHz, DMSO-d6 [2.50 ppm], ppm) δ = 15.92 (s, 1H), 10.42 (s, 1H), 9.74 (s, 1H), 7.65–7.62 (m, 2H), 6.84–6.77 (m, 2H), 3.19–3.16 (m, 2H), 2.85 (t, J = 7.2 Hz, 2H), 2.19 (s, 3H). Additional signals observable due to rotamerism.
DOI: 10.14272/llvfbekedcmpgv-mdwzmjqesa-n.1
title: C12H14N6O2
title: InChI=1S/C12H14N6O2/c1-8(9-2-4-10(19)5-3-9)13-16-12(20)7-6-11-14-17-18-15-11/h2-5,19H,6-7H2,1H3,(H,16,20)(H,14,15,17,18)/b13-8+

description: This is a physical chemical entity[CHEBI_24431] associated with a molecule[CHEBI_25367]. The molecule[CHEBI_25367] can be described by the following structural desciptors[cheminf_000085]: InChI descriptor[cheminf_000113]: InChI=1S/C12H14N6O2/c1-8(9-2-4-10(19)5-3-9)13-16-12(20)7-6-11-14-17-18-15-11/h2-5,19H,6-7H2,1H3,(H,16,20)(H,14,15,17,18)/b13-8+, and canonical SMILES descriptor[cheminf_000007]: O=C(CCc1nnn[nH]1)N/N=C(/c1ccc(cc1)O)\C, and by the IUPAC name[cheminf_000107]: . The physical chemical entity[CHEBI_24431] has a component solvent[CHEBI_46787] which is described by the canonical SMILES descriptor[cheminf_000007]: O=C(CCc1nnn[nH]1)N/N=C(/c1ccc(cc1)O)\C The physical chemical entity[CHEBI_24431] has the following Sample ID as registered in the research data repository chemotion (www.chemotion-repository.net, https://doi.org/10.25504/FAIRsharing.iagXcR): CRS-33437 The physical chemical entity[CHEBI_24431] can be described by the physical descriptors [CHEMINF_000025]: Melting point descriptor[CHEMINF_000256]: 256.0 (°C) Boiling point descriptor[CHEMINF_000257]: Refractive index descriptor[CHEMINF_000253]: The physical chemical entity[CHEBI_24431] can be further described by the following assays[OBI:0000070][CHMO:0001133]: CHMO:0000636 | Fourier transform infrared spectroscopy (FTIR) CHMO:0000595 | 13C nuclear magnetic resonance spectroscopy (13C NMR) CHMO:0000593 | 1H nuclear magnetic resonance spectroscopy (1H NMR) CHMO:0000498 | high-resolution mass spectrometry (HRMS) The physical chemical entity[CHEBI_24431] was deposited to the Molecule Archive of the Karlsruhe Insitute of Technology (KIT) with the following Sample ID: Used ontologies: CHEBI - Chemical Entities of Biological Interest CHEMINF - chemical information ontology (information entities about chemical entities) CHMO - Chemical Methods Ontology OBI - Ontology for Biomedical Investigations
DOI: 10.14272/llvfbekedcmpgv-mdwzmjqesa-n/chmo0000636
title: Fourier transform infrared spectroscopy (FTIR) ()
title: InChI=1S/C12H14N6O2/c1-8(9-2-4-10(19)5-3-9)13-16-12(20)7-6-11-14-17-18-15-11/h2-5,19H,6-7H2,1H3,(H,16,20)(H,14,15,17,18)/b13-8+

description: dataset for Fourier transform infrared spectroscopy (FTIR) IR (ATR, ṽ) = 3240 (w), 3222 (w), 3211 (w), 3186 (w), 3172 (w), 2586 (w), 2457 (w), 1649 (vs), 1616 (m), 1593 (m), 1541 (s), 1510 (vs), 1437 (s), 1415 (m), 1377 (m), 1367 (m), 1311 (s), 1257 (vs), 1232 (vs), 1173 (s), 1115 (w), 1099 (m), 1045 (s), 1011 (w), 997 (vs), 964 (m), 933 (s), 899 (m), 839 (vs), 822 (vs), 781 (w), 760 (w), 733 (s), 721 (m), 683 (s), 660 (m), 644 (s), 594 (m), 561 (vs), 523 (w), 503 (w), 422 (w), 417 (w) cm–1.
DOI: 10.14272/llvfbekedcmpgv-mdwzmjqesa-n/chmo0000498
title: high-resolution mass spectrometry (HRMS) ()
title: InChI=1S/C12H14N6O2/c1-8(9-2-4-10(19)5-3-9)13-16-12(20)7-6-11-14-17-18-15-11/h2-5,19H,6-7H2,1H3,(H,16,20)(H,14,15,17,18)/b13-8+

description: dataset for high-resolution mass spectrometry (HRMS) HRMS–ESI (C12H15N6O2+) (m/z): calcd 275.1251, found 275.1300.
DOI: 10.14272/llvfbekedcmpgv-mdwzmjqesa-n/chmo0000595
title: 13C nuclear magnetic resonance spectroscopy (13C NMR) ()
title: InChI=1S/C12H14N6O2/c1-8(9-2-4-10(19)5-3-9)13-16-12(20)7-6-11-14-17-18-15-11/h2-5,19H,6-7H2,1H3,(H,16,20)(H,14,15,17,18)/b13-8+

description: dataset for 13C nuclear magnetic resonance spectroscopy (13C NMR) 13C NMR (100 MHz, DMSO-d6 [39.5 ppm], ppm) δ = 173.0, 167.1, 158.5, 151.8, 129.0, 127.5 (2C), 115.1 (2C), 30.0, 18.0, 13.4. Additional signals observable due to rotamerism.
DOI: 10.14272/twkuaklzoiabhj-uhfffaoysa-n/chmo0000498
title: high-resolution mass spectrometry (HRMS) (2-(2H-tetrazol-5-yl)acetohydrazide)
title: InChI=1S/C3H6N6O/c4-5-3(10)1-2-6-8-9-7-2/h1,4H2,(H,5,10)(H,6,7,8,9)

description: dataset for high-resolution mass spectrometry (HRMS) HRMS–ESI (C3H6N6O) (m/z): calcd 141.0530, found 141.0514.
DOI: 10.14272/twkuaklzoiabhj-uhfffaoysa-n/chmo0000595
title: 13C nuclear magnetic resonance spectroscopy (13C NMR) (2-(2H-tetrazol-5-yl)acetohydrazide)
title: InChI=1S/C3H6N6O/c4-5-3(10)1-2-6-8-9-7-2/h1,4H2,(H,5,10)(H,6,7,8,9)

description: dataset for 13C nuclear magnetic resonance spectroscopy (13C NMR) 13C NMR (100 MHz, ppm) δ = 168.5, 155.5, 31.6.
DOI: 10.14272/twkuaklzoiabhj-uhfffaoysa-n/chmo0000636
title: Fourier transform infrared spectroscopy (FTIR) (2-(2H-tetrazol-5-yl)acetohydrazide)
title: InChI=1S/C3H6N6O/c4-5-3(10)1-2-6-8-9-7-2/h1,4H2,(H,5,10)(H,6,7,8,9)

description: dataset for Fourier transform infrared spectroscopy (FTIR) IR (ATR, ṽ) = 3275 (m), 3122 (m), 3116 (m), 3103 (m), 3089 (m), 3080 (m), 3070 (m), 3060 (m), 3051 (m), 3037 (m), 3030 (m), 3001 (m), 2978 (m), 2945 (m), 2939 (m), 2920 (m), 2900 (m), 2877 (m), 2835 (s), 2819 (m), 2800 (m), 2789 (m), 2779 (m), 2756 (m), 2744 (m), 2723 (m), 2667 (m), 2659 (m), 2634 (m), 1674 (vs), 1624 (s), 1568 (vs), 1525 (s), 1466 (s), 1437 (s), 1410 (vs), 1348 (s), 1155 (s), 1122 (vs), 1103 (s), 1090 (vs), 1059 (s), 1030 (vs), 957 (vs), 731 (m), 704 (s), 592 (vs), 482 (vs), 451 (vs), 445 (vs), 415 (s) cm–1.
DOI: 10.14272/twkuaklzoiabhj-uhfffaoysa-n.1
title: 2-(2H-tetrazol-5-yl)acetohydrazide
title: InChI=1S/C3H6N6O/c4-5-3(10)1-2-6-8-9-7-2/h1,4H2,(H,5,10)(H,6,7,8,9)

description: This is a physical chemical entity[CHEBI_24431] associated with a molecule[CHEBI_25367]. The molecule[CHEBI_25367] can be described by the following structural desciptors[cheminf_000085]: InChI descriptor[cheminf_000113]: InChI=1S/C3H6N6O/c4-5-3(10)1-2-6-8-9-7-2/h1,4H2,(H,5,10)(H,6,7,8,9), and canonical SMILES descriptor[cheminf_000007]: NNC(=O)Cc1nnn[nH]1, and by the IUPAC name[cheminf_000107]: 2-(2H-tetrazol-5-yl)acetohydrazide. The physical chemical entity[CHEBI_24431] has a component solvent[CHEBI_46787] which is described by the canonical SMILES descriptor[cheminf_000007]: NNC(=O)Cc1nnn[nH]1 The physical chemical entity[CHEBI_24431] has the following Sample ID as registered in the research data repository chemotion (www.chemotion-repository.net, https://doi.org/10.25504/FAIRsharing.iagXcR): CRS-33359 The physical chemical entity[CHEBI_24431] can be described by the physical descriptors [CHEMINF_000025]: Melting point descriptor[CHEMINF_000256]: 158.0 (°C) Boiling point descriptor[CHEMINF_000257]: Refractive index descriptor[CHEMINF_000253]: The physical chemical entity[CHEBI_24431] can be further described by the following assays[OBI:0000070][CHMO:0001133]: CHMO:0000636 | Fourier transform infrared spectroscopy (FTIR) CHMO:0000593 | 1H nuclear magnetic resonance spectroscopy (1H NMR) CHMO:0000595 | 13C nuclear magnetic resonance spectroscopy (13C NMR) CHMO:0000498 | high-resolution mass spectrometry (HRMS) The physical chemical entity[CHEBI_24431] was deposited to the Molecule Archive of the Karlsruhe Insitute of Technology (KIT) with the following Sample ID: Used ontologies: CHEBI - Chemical Entities of Biological Interest CHEMINF - chemical information ontology (information entities about chemical entities) CHMO - Chemical Methods Ontology OBI - Ontology for Biomedical Investigations
DOI: 10.14272/twkuaklzoiabhj-uhfffaoysa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) (2-(2H-tetrazol-5-yl)acetohydrazide)
title: InChI=1S/C3H6N6O/c4-5-3(10)1-2-6-8-9-7-2/h1,4H2,(H,5,10)(H,6,7,8,9)

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR) 1H NMR (400 MHz, DMSO-d6 [2.50 ppm], ppm) δ = 3.54 (s, 2H). Missing signals due to H/D exchange (4H, NH, NH, NH2).
DOI: 10.5258/soton/d2431
title: Dataset in support of the Southampton doctoral thesis "Co-creating a new theory of gender beyond the binary: A Delphi study"

description: Dataset underpinning Chapter Three of the thesis, "Gender Representation Beyond the Binary: New Possibilities and Understandings" by Jamie Thomas Wilson.
DOI: 10.14272/zhullrquwlyjhw-uhfffaoysa-n/chmo0000595
title: 13C nuclear magnetic resonance spectroscopy (13C NMR) (1,2-dihydrobenzo[f][1,3]benzoxazin-3-one)
title: InChI=1S/C12H9NO2/c14-12-13-7-10-9-4-2-1-3-8(9)5-6-11(10)15-12/h1-6H,7H2,(H,13,14)

description: dataset for 13C nuclear magnetic resonance spectroscopy (13C NMR) 13C NMR (100 MHz, DMSO-d6 [39.5 ppm], ppm) δ = 149.9, 147.5, 130.4, 129.7, 129.6, 128.9, 127.8, 125.6, 122.9, 117.1, 110.4, 40.0.
DOI: 10.14272/zhullrquwlyjhw-uhfffaoysa-n.1
title: 1,2-dihydrobenzo[f][1,3]benzoxazin-3-one
title: InChI=1S/C12H9NO2/c14-12-13-7-10-9-4-2-1-3-8(9)5-6-11(10)15-12/h1-6H,7H2,(H,13,14)

description: This is a physical chemical entity[CHEBI_24431] associated with a molecule[CHEBI_25367]. The molecule[CHEBI_25367] can be described by the following structural desciptors[cheminf_000085]: InChI descriptor[cheminf_000113]: InChI=1S/C12H9NO2/c14-12-13-7-10-9-4-2-1-3-8(9)5-6-11(10)15-12/h1-6H,7H2,(H,13,14), and canonical SMILES descriptor[cheminf_000007]: O=C1NCc2c(O1)ccc1c2cccc1, and by the IUPAC name[cheminf_000107]: 1,2-dihydrobenzo[f][1,3]benzoxazin-3-one. The physical chemical entity[CHEBI_24431] has a component solvent[CHEBI_46787] which is described by the canonical SMILES descriptor[cheminf_000007]: O=C1NCc2c(O1)ccc1c2cccc1 The physical chemical entity[CHEBI_24431] has the following Sample ID as registered in the research data repository chemotion (www.chemotion-repository.net, https://doi.org/10.25504/FAIRsharing.iagXcR): CRS-33443 The physical chemical entity[CHEBI_24431] can be described by the physical descriptors [CHEMINF_000025]: Melting point descriptor[CHEMINF_000256]: 180.0 (°C) Boiling point descriptor[CHEMINF_000257]: Refractive index descriptor[CHEMINF_000253]: The physical chemical entity[CHEBI_24431] can be further described by the following assays[OBI:0000070][CHMO:0001133]: CHMO:0000636 | Fourier transform infrared spectroscopy (FTIR) CHMO:0000593 | 1H nuclear magnetic resonance spectroscopy (1H NMR) CHMO:0000595 | 13C nuclear magnetic resonance spectroscopy (13C NMR) CHMO:0001075 | elemental analysis (EA) The physical chemical entity[CHEBI_24431] was deposited to the Molecule Archive of the Karlsruhe Insitute of Technology (KIT) with the following Sample ID: Used ontologies: CHEBI - Chemical Entities of Biological Interest CHEMINF - chemical information ontology (information entities about chemical entities) CHMO - Chemical Methods Ontology OBI - Ontology for Biomedical Investigations
DOI: 10.14272/zhullrquwlyjhw-uhfffaoysa-n/chmo0001075
title: elemental analysis (EA) (1,2-dihydrobenzo[f][1,3]benzoxazin-3-one)
title: InChI=1S/C12H9NO2/c14-12-13-7-10-9-4-2-1-3-8(9)5-6-11(10)15-12/h1-6H,7H2,(H,13,14)

description: dataset for elemental analysis (EA) calcd.: C, 72.35; H, 4.55; N, 7.03; found: C, 72.54; H, 4.32; N, 7.41
DOI: 10.14272/zhullrquwlyjhw-uhfffaoysa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) (1,2-dihydrobenzo[f][1,3]benzoxazin-3-one)
title: InChI=1S/C12H9NO2/c14-12-13-7-10-9-4-2-1-3-8(9)5-6-11(10)15-12/h1-6H,7H2,(H,13,14)

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR) 1H NMR (400 MHz, DMSO-d6 [2.50 ppm], ppm) δ = 8.23 (s, 1H), 7.94 (d, J = 8.0 Hz, 1H), 7.89 (d, J = 8.8 Hz, 1H), 7.72 (d, J = 8.5 Hz, 1H), 7.59 (t, J = 7.7 Hz, 1H), 7.52–7.48 (m, 1H), 7.22 (d, J = 8.8 Hz, 1H), 4.78 (s, 2H).
DOI: 10.14272/zhullrquwlyjhw-uhfffaoysa-n/chmo0000636
title: Fourier transform infrared spectroscopy (FTIR) (1,2-dihydrobenzo[f][1,3]benzoxazin-3-one)
title: InChI=1S/C12H9NO2/c14-12-13-7-10-9-4-2-1-3-8(9)5-6-11(10)15-12/h1-6H,7H2,(H,13,14)

description: dataset for Fourier transform infrared spectroscopy (FTIR) IR (ATR, ṽ) = 3241 (w), 3151 (m), 3110 (w), 1733 (vs), 1634 (m), 1589 (w), 1515 (s), 1506 (s), 1465 (m), 1441 (m), 1401 (vs), 1381 (vs), 1348 (m), 1301 (m), 1216 (vs), 1171 (vs), 1142 (m), 1115 (vs), 1064 (m), 990 (s), 912 (m), 864 (m), 794 (vs), 757 (vs), 743 (vs), 708 (vs), 694 (s), 591 (vs), 568 (m), 519 (m), 508 (w), 492 (m), 414 (vs) cm–1.
DOI: 10.17028/rd.lboro.22838198
title: Supplementary information files for Effect of the perception of breakfast consumption on subsequent appetite and energy intake in healthy males

description: Supplementary files for article Effect of the perception of breakfast consumption on subsequent appetite and energy intake in healthy males <br> Purpose: This study aimed to assess the effects of consuming a very-low-energy placebo breakfast on subsequent appetite and lunch energy intake. <br> Methods: Fourteen healthy males consumed water-only (WAT), very-low-energy, viscous placebo (containing water, low-calorie flavoured squash, and xanthan gum; ~ 16 kcal; PLA), and whole-food (~ 573 kcal; FOOD) breakfasts in a randomised order. Subjects were blinded to the energy content of PLA and specific study aims. Venous blood samples were collected pre-breakfast, 60- and 180-min post-breakfast to assess plasma acylated ghrelin and peptide tyrosine tyrosine concentrations. Subjective appetite was measured regularly, and energy intake was assessed at an ad libitum lunch meal 195-min post-breakfast. <br> Results: Lunch energy intake was lower during FOOD compared to WAT (P &lt; 0.05), with no further differences between trials (P ≥ 0.132). Cumulative energy intake (breakfast plus lunch) was lower during PLA (1078 ± 274 kcal) and WAT (1093 ± 249 kcal), compared to FOOD (1554 ± 301 kcal; P &lt; 0.001). Total area under the curve (AUC) for hunger, desire to eat and prospective food consumption were lower, and fullness was greater during PLA and FOOD compared to WAT (P &lt; 0.05). AUC for hunger was lower during FOOD compared to PLA (P &lt; 0.05). During FOOD, acylated ghrelin was suppressed compared to PLA and WAT at 60 min (P &lt; 0.05), with no other hormonal differences between trials (P ≥ 0.071). <br> Conclusion: Consuming a very-low-energy placebo breakfast does not alter energy intake at lunch but may reduce cumulative energy intake across breakfast and lunch and attenuate elevations in subjective appetite associated with breakfast omission. <br> Trial registration: NCT04735783, 2nd February 2021, retrospectively registered. <br> <br>
DOI: 10.17028/rd.lboro.22838198.v1
title: Supplementary information files for Effect of the perception of breakfast consumption on subsequent appetite and energy intake in healthy males

description: Supplementary files for article Effect of the perception of breakfast consumption on subsequent appetite and energy intake in healthy males <br> Purpose: This study aimed to assess the effects of consuming a very-low-energy placebo breakfast on subsequent appetite and lunch energy intake. <br> Methods: Fourteen healthy males consumed water-only (WAT), very-low-energy, viscous placebo (containing water, low-calorie flavoured squash, and xanthan gum; ~ 16 kcal; PLA), and whole-food (~ 573 kcal; FOOD) breakfasts in a randomised order. Subjects were blinded to the energy content of PLA and specific study aims. Venous blood samples were collected pre-breakfast, 60- and 180-min post-breakfast to assess plasma acylated ghrelin and peptide tyrosine tyrosine concentrations. Subjective appetite was measured regularly, and energy intake was assessed at an ad libitum lunch meal 195-min post-breakfast. <br> Results: Lunch energy intake was lower during FOOD compared to WAT (P &lt; 0.05), with no further differences between trials (P ≥ 0.132). Cumulative energy intake (breakfast plus lunch) was lower during PLA (1078 ± 274 kcal) and WAT (1093 ± 249 kcal), compared to FOOD (1554 ± 301 kcal; P &lt; 0.001). Total area under the curve (AUC) for hunger, desire to eat and prospective food consumption were lower, and fullness was greater during PLA and FOOD compared to WAT (P &lt; 0.05). AUC for hunger was lower during FOOD compared to PLA (P &lt; 0.05). During FOOD, acylated ghrelin was suppressed compared to PLA and WAT at 60 min (P &lt; 0.05), with no other hormonal differences between trials (P ≥ 0.071). <br> Conclusion: Consuming a very-low-energy placebo breakfast does not alter energy intake at lunch but may reduce cumulative energy intake across breakfast and lunch and attenuate elevations in subjective appetite associated with breakfast omission. <br> Trial registration: NCT04735783, 2nd February 2021, retrospectively registered. <br> <br>
DOI: 10.23728/b2share.c3dc5ae725b94c6580bfce743127ede6
title: Gesäuse-Johnsbachtal - Austria, Soil texture

description: Solid texture data of the Gesäuse-Johnsbachtal site
DOI: 10.6084/m9.figshare.22140839
title: Assessing Sensitivity to Unconfoundedness: Estimation and Inference

description: This article provides a set of methods for quantifying the robustness of treatment effects estimated using the unconfoundedness assumption. Specifically, we estimate and do inference on bounds for various treatment effect parameters, like the Average Treatment Effect (ATE) and the average effect of treatment on the treated (ATT), under nonparametric relaxations of the unconfoundedness assumption indexed by a scalar sensitivity parameter <i>c</i>. These relaxations allow for limited selection on unobservables, depending on the value of <i>c</i>. For large enough <i>c</i>, these bounds equal the no assumptions bounds. Using a nonstandard bootstrap method, we show how to construct confidence bands for these bound functions which are uniform over all values of <i>c</i>. We illustrate these methods with an empirical application to the National Supported Work Demonstration program. We implement these methods in the companion Stata module tesensitivity for easy use in practice.
DOI: 10.6084/m9.figshare.22140839.v2
title: Assessing Sensitivity to Unconfoundedness: Estimation and Inference

description: This article provides a set of methods for quantifying the robustness of treatment effects estimated using the unconfoundedness assumption. Specifically, we estimate and do inference on bounds for various treatment effect parameters, like the Average Treatment Effect (ATE) and the average effect of treatment on the treated (ATT), under nonparametric relaxations of the unconfoundedness assumption indexed by a scalar sensitivity parameter <i>c</i>. These relaxations allow for limited selection on unobservables, depending on the value of <i>c</i>. For large enough <i>c</i>, these bounds equal the no assumptions bounds. Using a nonstandard bootstrap method, we show how to construct confidence bands for these bound functions which are uniform over all values of <i>c</i>. We illustrate these methods with an empirical application to the National Supported Work Demonstration program. We implement these methods in the companion Stata module tesensitivity for easy use in practice.
DOI: 10.6084/m9.figshare.22140839.v1
title: Assessing Sensitivity to Unconfoundedness: Estimation and Inference

description: This paper provides a set of methods for quantifying the robustness of treatment effects estimated using the unconfoundedness assumption. Specifically, we estimate and do inference on bounds on various treatment effect parameters, like the average treatment effect (ATE) and the average effect of treatment on the treated (ATT), under nonparametric relaxations of the unconfoundedness assumption indexed by a scalar sensitivity parameter c. These relaxations allow for limited selection on unobservables, depending on the value of c. For large enough c, these bounds equal the no assumptions bounds. Using a non-standard bootstrap method, we show how to construct confidence bands for these bound functions which are uniform over all values of c. We illustrate these methods with an empirical application to the National Supported Work Demonstration program. We implement these methods in the companion Stata module tesensitivity for easy use in practice.
DOI: 10.5517/ccdc.csd.cc2269rc
title: CCDC 1912692: Experimental Crystal Structure Determination

description: Related Article: Lorenzo G. Borrego, Rocío Recio, Eleuterio Álvarez, Antonio Sánchez-Coronilla, Noureddine Khiar, Inmaculada Fernández|2019|Org.Lett.|21|6513|doi:10.1021/acs.orglett.9b02405
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2269sd
title: CCDC 1912693: Experimental Crystal Structure Determination

description: Related Article: Lorenzo G. Borrego, Rocío Recio, Eleuterio Álvarez, Antonio Sánchez-Coronilla, Noureddine Khiar, Inmaculada Fernández|2019|Org.Lett.|21|6513|doi:10.1021/acs.orglett.9b02405
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2269tf
title: CCDC 1912694: Experimental Crystal Structure Determination

description: Related Article: Lorenzo G. Borrego, Rocío Recio, Eleuterio Álvarez, Antonio Sánchez-Coronilla, Noureddine Khiar, Inmaculada Fernández|2019|Org.Lett.|21|6513|doi:10.1021/acs.orglett.9b02405
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.34740/kaggle/dsv/5698357
title: 2021 World Population (updated daily)
DOI: 10.14272/razitxfwtapvox-uhfffaoysa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) ()
title: InChI=1S/C8H12N6O/c15-8(5-7-10-13-14-11-7)12-9-6-3-1-2-4-6/h1-5H2,(H,12,15)(H,10,11,13,14)

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR) 1H NMR (400 MHz, DMSO-d6 [2.50 ppm], ppm) δ = 16.18 (s, 1H), 10.41 (s, 1H), 4.25 (s, 2H), 2.35–2.28 (m, 4H), 1.80–1.67 (m, 4H). Additional signals observable due to rotamerism.
DOI: 10.14272/razitxfwtapvox-uhfffaoysa-n/chmo0000595
title: 13C nuclear magnetic resonance spectroscopy (13C NMR) ()
title: InChI=1S/C8H12N6O/c15-8(5-7-10-13-14-11-7)12-9-6-3-1-2-4-6/h1-5H2,(H,12,15)(H,10,11,13,14)

description: dataset for 13C nuclear magnetic resonance spectroscopy (13C NMR) 13C NMR (100 MHz, DMSO-d6 [39.5 ppm], ppm) δ = 168.2, 163.9, 151.0, 33.0, 28.3, 28.2, 24.4, 24.3. Additional signals observable due to rotamerism.